Welcome To The Dark Matter Digital Network

Many more people could still die from mad cow disease

It’s finally happened. Until now, vCJD – the deadly disease caused by infection with BSE, or “mad cow disease” – has struck only people with a certain genetic makeup. Now, for the first time, researchers have confirmed a case in someone with different genes – a finding that could mean we have been misdiagnosing a new wave of cases. In late 2014, a 36-year-old man in the UK started developing aggressive personality changes, memory loss and problems walking. The symptoms and brain scans were typical of ordinary CJD, a rare disease of elderly people not linked to BSE. But because he was so young, his prions were double-checked after he died in February 2016. In fact he had vCJD, the kind caused by BSE. The surprise was in his DNA. BSE is caused by a misshapen protein, called a prion. It spreads when prions in the blood interact with the normal version of the protein, and pass on the deformation. These prions build up in the brain, eventually causing neural disorders and death. But the normal protein comes in two forms. Either it has the amino acid methionine (M) at position 129 in the amino acid chain that makes up the protein, or it has valine (V). We inherit a gene for this protein from each of our parents, and there are three possibilities – people whose bodies only make the M form, people who only have the V form, or people who make some of both. Second wave All 223 people previously diagnosed with vCJD worldwide, including 177 in the UK, made only the M type of the protein. But the 36-year-old man had a mix of both – the first such case, apart from one unconfirmed case in 2008. The reason it has taken so long for such a case to appear is likely because people with both types of protein take longer to develop the symptoms of vCJD. Only the M form can be deformed by the BSE prion, and because these people have less M protein, it takes longer for the prion to build up in their body. Kuru, another human prion disease, is already known to take longer to develop in people with both forms of the protein. Read More: New Scientist

Leave a comment